Suppr超能文献

基于瑜伽和阿育吠陀的整合疗法在 COVID-19/SARS-CoV-2 合并多种合并症高危病例治疗中的应用:病例报告。

The use of integrative therapy based on Yoga and Ayurveda in the treatment of a high-risk case of COVID-19/SARS-CoV-2 with multiple comorbidities: a case report.

机构信息

Department of Ayurveda and Holistic Health, Dev Sanskriti Vishwavidyalaya, Haridwar, India.

Ayurveda physician and yoga expert, Noida, India.

出版信息

J Med Case Rep. 2021 Feb 24;15(1):95. doi: 10.1186/s13256-020-02624-1.

Abstract

BACKGROUND

We report a high-risk case of a coronavirus disease 19 (COVID-19)-positive patient with comorbidities including diabetes mellitus (DM), hypertension (HTN), hypothyroidism and chronic kidney disease (CKD), treated successfully using an integrative therapy plan based on Ayurveda and Yoga, along with government-mandated compulsory modern western medicine (MWM) treatment. Recently, some evidence has been emerging on the use of Ayurveda for treatment of COVID-19. The classical texts of Ayurvedic medicine such as Charaka Samhita and Sushruta Samhita contain descriptions of pandemics of similar proportions and describe them as Janapadoddhvansa, meaning the destruction of communities, along with their causes and treatment.

CASE PRESENTATION

The case reported herein is a 55-year-old man from Delhi, India, with confirmed (tested) COVID-19, who first took MWM for 7 days before seeking integrative therapy. The patient has comorbidities including DM, HTN, hypothyroidism and CKD and had developed symptoms including fever (which was resolved by the time integrative therapy was started), sore throat, dry cough, body aches, weakness, bad taste and smell, and heaviness in the abdomen. Based on the patient's symptoms and comorbidities, a treatment plan including Ayurvedic medicines, Yoga protocol, dietary recommendations and lifestyle modifications was prescribed by a registered Ayurveda doctor and a Yoga consultant. The patient started experiencing improvement in all the symptoms within 2 days after starting the treatment; he reported approximately [Formula: see text] relief from the symptoms after 5 days, and almost complete relief within 9 days. Also, the blood sugar levels (both fasting blood sugar [FBS] and postprandial blood sugar [PPBS]) exhibited significant improvement after 5 days, and decreased to within the normal range within 12 days. Besides relief in symptoms, the patient's real-time reverse transcription polymerase chain reaction (RT-PCR) test done on the 19th day returned negative results.

CONCLUSIONS

Integrative therapy was found to be effective in mitigating the symptoms of COVID-19 in this patient with multiple comorbidities. Moreover, a significant improvement in blood sugar levels (not under control with modern medicine) was also achieved. Integrative therapy based on the classical texts of Ayurveda and Yoga may offer a promising and scalable treatment option for COVID-19 patients. A case series or a suitably designed randomized controlled trial is needed to assess its efficacy.

摘要

背景

我们报告了一个患有冠状病毒病 19(COVID-19)的高危病例,该患者合并有糖尿病(DM)、高血压(HTN)、甲状腺功能减退症和慢性肾脏病(CKD)等疾病,成功地采用了基于阿育吠陀和瑜伽的综合治疗计划,同时还接受了政府强制的现代西药(MWM)治疗。最近,有证据表明阿育吠陀可用于 COVID-19 的治疗。阿育吠陀医学的经典著作,如《查拉卡本集》和《苏斯拉他本集》,都有类似比例的大流行描述,并将其描述为“Janapadoddhvansa”,即社区的破坏,以及它们的原因和治疗方法。

病例介绍

本报告的病例是一名来自印度德里的 55 岁男性,确诊(经检测)COVID-19,他在寻求综合治疗前先接受了 MWM 治疗 7 天。该患者合并有 DM、HTN、甲状腺功能减退症和 CKD,出现了发热(在开始接受综合治疗时已退热)、咽痛、干咳、全身疼痛、乏力、味觉和嗅觉丧失以及腹部沉重等症状。根据患者的症状和合并症,由注册阿育吠陀医生和瑜伽顾问制定了包括阿育吠陀药物、瑜伽方案、饮食建议和生活方式改变在内的治疗计划。患者在开始治疗后 2 天内所有症状均开始改善;他报告称,在第 5 天左右症状缓解约[Formula: see text],第 9 天几乎完全缓解。此外,5 天后血糖水平(空腹血糖[FBS]和餐后血糖[PPBS])也明显改善,12 天内降至正常范围。除症状缓解外,患者在第 19 天进行的实时逆转录聚合酶链反应(RT-PCR)检测结果也呈阴性。

结论

综合治疗被发现对该合并多种疾病的 COVID-19 患者的症状有效。此外,血糖水平也有显著改善(现代医学无法控制)。基于阿育吠陀和瑜伽的经典著作的综合治疗可能为 COVID-19 患者提供一种有前途且可扩展的治疗选择。需要进行病例系列或适当设计的随机对照试验来评估其疗效。

相似文献

2
Management of COVID - 19 with Siddha and Western Medicine - An Integrative Case Report.
J Family Med Prim Care. 2022 Jul;11(7):4062-4066. doi: 10.4103/jfmpc.jfmpc_1953_21. Epub 2022 Jul 22.
3
An 'Ayurveda-Biology' platform for integrative diabetes management.
J Ethnopharmacol. 2021 Mar 25;268:113575. doi: 10.1016/j.jep.2020.113575. Epub 2020 Nov 9.
4
Combined Ayurveda and Yoga Practices for Newly Diagnosed Type 2 Diabetes Mellitus: A Controlled Trial.
Complement Med Res. 2018;25(1):16-23. doi: 10.1159/000464441. Epub 2017 Sep 29.
5
Public Health Approach of Ayurveda and Yoga for COVID-19 Prophylaxis.
J Altern Complement Med. 2020 May;26(5):360-364. doi: 10.1089/acm.2020.0129. Epub 2020 Apr 20.
6
Outcomes from a Whole-Systems Ayurvedic Medicine and Yoga Therapy Treatment for Obesity Pilot Study.
J Altern Complement Med. 2019 Mar;25(S1):S124-S137. doi: 10.1089/acm.2018.0448.
7
Integrative management of critical case of Covid 19 with and modern medicine: A case report.
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100496. doi: 10.1016/j.jaim.2021.07.012. Epub 2021 Jul 28.

引用本文的文献

3
Impact assessment of integrated-pathy on cancer-related fatigue in cancer patients: an observational study.
J Health Popul Nutr. 2024 Apr 4;43(1):48. doi: 10.1186/s41043-024-00537-z.
6
Ayurveda management of pulmonary mycosis: an integrative approach: a case report.
J Med Case Rep. 2023 Feb 8;17(1):48. doi: 10.1186/s13256-022-03736-6.
7
Relationship between physical exercise and COVID-19 (SARS-CoV-2): systematic review.
Sport Sci Health. 2023;19(1):55-67. doi: 10.1007/s11332-022-01028-6. Epub 2023 Jan 7.

本文引用的文献

1
COVID-19: Environment concern and impact of Indian medicinal system.
J Environ Chem Eng. 2020 Oct;8(5):104144. doi: 10.1016/j.jece.2020.104144. Epub 2020 Jun 6.
2
The role of Chinese medicine in COVID-19 pneumonia: A systematic review and meta-analysis.
Am J Emerg Med. 2020 Oct;38(10):2153-2159. doi: 10.1016/j.ajem.2020.06.069. Epub 2020 Jul 8.
3
An ayurvedic perspective along with in silico study of the drugs for the management of SARS-CoV-2.
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100343. doi: 10.1016/j.jaim.2020.07.002. Epub 2020 Jul 21.
4
Combating COVID-19 with integrated traditional Chinese and Western medicine in China.
Acta Pharm Sin B. 2020 Jul;10(7):1149-1162. doi: 10.1016/j.apsb.2020.06.009. Epub 2020 Jun 27.
5
Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis.
J Integr Med. 2020 Sep;18(5):385-394. doi: 10.1016/j.joim.2020.07.008. Epub 2020 Jul 31.
6
Enlightenment from clinical trials on Chinese medicine for coronavirus disease 2019 (COVID-19).
Integr Med Res. 2020 Sep;9(3):100481. doi: 10.1016/j.imr.2020.100481. Epub 2020 Jul 17.
8
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors.
Brain Behav Immun. 2020 Oct;89:594-600. doi: 10.1016/j.bbi.2020.07.037. Epub 2020 Jul 30.
9
Ayurvedic treatment of COVID-19: A case report.
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100329. doi: 10.1016/j.jaim.2020.06.001. Epub 2020 Jun 19.
10
Yoga for COVID-19.
Int J Yoga. 2020 May-Aug;13(2):87-88. doi: 10.4103/ijoy.IJOY_27_20. Epub 2020 May 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验